This record was last updated March 28, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, single-center, phase II study，to evaluate the efficacy and safety of icariin soft capsules combined with TACE as adjuvant therapy in hepatocellular carcinoma (HCC) patients at high risk of recurrence after resection.